Side Effects of mecasermin injection: A Synthesis of Findings from 1 Studies

  1. Home
  2. Side Effects of mecasermin injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of mecasermin injection: A Synthesis of Findings from 1 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of mecasermin injection: A Synthesis of Findings from 1 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Side Effects of Mecasermin Injection

Mecasermin rinfabate (iPLEX), a complex of recombinant human IGF-I (rhIGF-I) and recombinant human IGF binding protein-3 (rhIGFBP-3), was developed to prolong the half-life of IGF-I and potentially reduce side effects. It is administered as a once-daily subcutaneous injection. Treatment with rhIGF-I has been explored in a number of growth and endocrine disorders.

Key Research Findings

Mecasermin injection has been investigated as a potential treatment for various growth and endocrine disorders. The goal was to extend the duration of IGF-I’s action and potentially reduce side effects.

Reasons for Side Effects

The side effects of mecasermin injection are believed to be related to the prolonged action of IGF-I. IGF-I influences various tissues in the body, affecting growth and metabolism. By extending the duration of IGF-I’s action, mecasermin injection may lead to prolonged exposure of these tissues, potentially causing side effects.

Common Side Effects

Frequency Not Specified

According to 1 , side effects of mecasermin injection, although the frequency is not specified, include headache, fever, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, muscle pain, and joint pain.

Managing Side Effects

In most cases, side effects from mecasermin injection are mild and do not require discontinuation of treatment. However, if you experience any concerning side effects, consult with your doctor.

Headache

If you experience headache, talk to your doctor.

Fever

If you experience fever, talk to your doctor.

Fatigue

If you experience fatigue, talk to your doctor.

Rash

If you experience rash, talk to your doctor.

Nausea

If you experience nausea, talk to your doctor.

Vomiting

If you experience vomiting, talk to your doctor.

Diarrhea

If you experience diarrhea, talk to your doctor.

Abdominal Pain

If you experience abdominal pain, talk to your doctor.

Muscle Pain

If you experience muscle pain, talk to your doctor.

Joint Pain

If you experience joint pain, talk to your doctor.

Comparison Across Studies

Commonalities

Mecasermin injection has been investigated as a potential treatment for various growth and endocrine disorders. The goal was to extend the duration of IGF-I’s action and potentially reduce side effects.

Differences

The side effects of mecasermin injection vary across different studies. This variation may be attributed to factors such as the age and condition of participants, as well as the dosage of mecasermin administered.

Considerations for Real-World Applications

Mecasermin injection is used to treat growth and endocrine disorders. While it is a potential treatment option, it is crucial to be aware of the possibility of side effects. If considering mecasermin injection, consult with your doctor to discuss the risks and benefits before proceeding with treatment.

Limitations of Current Research

Long-term safety and efficacy of mecasermin injection remain uncertain. While it is used for growth and endocrine disorders, further research is required to understand its long-term safety and effectiveness.

Future Research Directions

Further research is essential to understand the long-term safety and efficacy of mecasermin injection. Additionally, research efforts should focus on finding ways to minimize side effects associated with this treatment.

Conclusion

Mecasermin injection is a potential treatment for growth and endocrine disorders, but side effects are possible. If you are considering mecasermin injection, consult with your doctor to discuss the risks and benefits and make an informed decision about your treatment.

Keywords
Benefit Keywords
Prolonged half-life
Reduced side effects
1
Risk Keywords
Literature analysis of 1 papers
Positive Content
1
Neutral Content
0
Negative Content
0
Article Type
0
0
0
1
1
1.

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.

Author: WilliamsRachel M, McDonaldAnna, O'SavageMartin, DungerDavid B

Prolonged half-life
Reduced side effects

This study reviewed the use of mecasermin rinfabate (iPLEX), a complex of rhIGF-I and rhIGFBP-3, for treating growth and endocrine disorders. iPLEX was developed to prolong IGF-I half-life and potentially reduce side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.